Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGCLA.L Regulatory News (GCLA)

  • There is currently no data for GCLA

Stabilisation Notice

19 Oct 2007 11:15

Credit Suisse Securities (Eur) Ltd19 October 2007 PRE-STABILISATION ANNOUNCEMENT Not for distribution, directly or indirectly, in or into the United States orany jurisdiction in which such distribution would be unlawful. Grupo Clarin 19th October 2007 Pre-Stabilisation Notice Pursuant to Core Dealing Rule 3060-3061, Credit Suisse Securities (Europe)Limited hereby notifies the London Stock Exchange that it and its affiliates maystabilise the offering of the Security below Credit Suisse Securities (Europe) Limited, hereby gives notice that theStabilising Manager(s) named below may stabilise the offer of the followingsecurities in accordance with Commission Regulation (EC) No. 2273/2003implementing the Market Abuse Directive (2003/6/EC). The securities: Issuer: Grupo Clarin ISIN US40052A2096 REGs US40052A1007 144aGuarantor (if any): Aggregate nominal amount 19,250,000(Offering): Description: GDR Ratio 1 GDR : 2 B Share Offer price: USD 18.50 Other offer terms: Stabilisation: Stabilising Manager(s): Credit Suisse Securities (Europe) Limited Contact Felipe Portillo 44 20 7888 6522 Stabilisation period expected 19th October 2007 at approximately 12.00pm London time;to start on: Stabilisation period expected 16th November 2007 (30 days after the proposed issue date of theto end no later than: securities) Over-allotment option 15 % of the Offering Existence, maximum size and The Stabilising Manager(s) may over-allot the securities conditions of use of to the extent permitted in accordance with applicable law. over-allotment facility: In connection with the offer of the above securities, the Stabilising Manager(s)may over-allot the securities or effect transactions with a view to supportingthe market price of the securities at a level higher than that which mightotherwise prevail. However, there is no assurance that the Stabilising Manager(s) will take any stabilisation action and any stabilisation action, if begun,may be ended at any time. Any stabilisation action or over-allotment shall beconducted in accordance with all applicable laws and rules. This announcement is for information purposes only and does not constitute aninvitation or offer to underwrite, subscribe for or otherwise acquire or disposeof any securities of the Issuer in any jurisdiction. This material was produced by Credit Suisse Securities (Europe) Limited, a firmregulated and authorised by The Financial Services Authority (the "FSA"). Thisannouncement and the offer of the securities to which it relates are onlyaddressed to and directed at persons outside the United Kingdom and persons inthe United Kingdom who have professional experience in matters related toinvestments or who are high net worth persons within article 12(5) of theFinancial Services and Markets Act 2000 (Financial Promotion) Order 2005 andmust not be acted on or relied on by other persons in the United Kingdom. In addition, if and to the extent that this announcement is communicated in, orthe offer of the securities to which it relates is made in, any EEA Member Statethat has implemented Directive 2003/71/EC (together with any applicableimplementing measures in any Member State, the "Prospectus Directive") beforethe publication of a prospectus in relation to the securities which has beenapproved by the competent authority in that Member State in accordance with theProspectus Directive (or which has been approved by a competent authority inanother Member State and notified to the competent authority in that MemberState in accordance with the Prospectus Directive), this announcement and theoffer are only addressed to and directed at persons in that Member State who arequalified investors within the meaning of the Prospectus Directive (or who areother persons to whom the offer may lawfully be addressed) and must not be actedon or relied on by other persons in that Member State. This announcement is not an offer of securities for sale into the United States.The securities have not been, and will not be, registered under the UnitedStates Securities Act of 1933 and may not be offered or sold in the UnitedStates absent registration or an exemption from registration. There will be nopublic offer of securities in the United States. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
13th Aug 20198:48 amRNSFirst Half and Second Quarter 2019 Results
6th Aug 20198:37 amRNSNotice of Results
24th May 20197:40 amRNSFirst Quarter 2019 Results (1Q19)
22nd May 20197:56 amRNSConference call and webcast for Q1 2019 results
8th May 20195:12 pmRNS[Replacement] Ordinary Shareholders' Meeting
8th May 20195:01 pmRNS[Replacement] Appointment of Company Authorities
8th May 20194:58 pmRNSAppointment of Company Authorities
3rd May 20198:34 amRNSGrupo Clarin Appoints Company Authorities
3rd May 20198:29 amRNSGCSA holds Annual Ordinary Shareholders' Meeting
29th Apr 20197:00 amRNSAnnual Financial Report
26th Apr 20198:05 amRNSDirectorate Change
17th Apr 20197:06 amRNSResponse to Shareholder Information Request
8th Apr 20192:40 pmRNSGrupo Clarín Publishes List of Errata
26th Mar 20195:05 pmRNSGrupo Clarín Calls Annual Shareholders' Meeting
12th Mar 20198:00 amRNSFourth Quarter and Full Year 2018 Results
14th Dec 20184:36 pmRNSPrice Monitoring Extension
23rd Nov 20185:47 pmRNSGrupo Clarin Assigns Credit to Cablevision Holding
9th Nov 20187:45 amRNSThird Quarter and Nine-Month 2018 Results
5th Nov 20187:00 amRNSConference call and webcast for Q3 2018 results
22nd Aug 20183:45 pmRNSSecond Price Monitoring Extn
22nd Aug 20183:40 pmRNSPrice Monitoring Extension
10th Aug 20187:00 amRNSFirst Half and Second Quarter 2018 Results
6th Aug 20187:00 amRNSNotice of Results
20th Jun 20187:00 amRNSGrupo Clarín Settles Claims
15th Jun 20183:45 pmRNSSecond Price Monitoring Extn
15th Jun 20183:40 pmRNSPrice Monitoring Extension
23rd May 20183:45 pmRNSSecond Price Monitoring Extn
23rd May 20183:40 pmRNSPrice Monitoring Extension
15th May 20183:45 pmRNSSecond Price Monitoring Extn
15th May 20183:40 pmRNSPrice Monitoring Extension
14th May 20183:40 pmRNSPrice Monitoring Extension
11th May 20187:00 amRNSGrupo Clarín Announces First Quarter 2018 Results
8th May 20187:00 amRNSConference call and webcast for Q1 2018 results
26th Apr 20187:00 amRNSAnnual Financial Report
23rd Apr 20187:46 amRNSAnnual Ordinary Shareholders' Meeting
10th Apr 20187:35 amRNSResponse to Information Request
22nd Mar 20187:00 amRNSGrupo Clarin Calls Annual Shareholders` Meeting
12th Mar 20187:00 amRNSFourth Quarter and Full Year 2017 Results
6th Mar 20189:51 amRNSNotice of Results
16th Feb 20187:00 amRNSDirector/PDMR Shareholding
3rd Jan 20188:31 amRNSDirectorate Change
29th Dec 20177:00 amRNSResignations of Alternate Board Members
15th Nov 201712:26 pmRNSDirectorate Change
10th Nov 20177:00 amRNS3rd Quarter and Nine-Month 2017 Results
3rd Nov 20177:00 amRNSCall and Presentation for Q3 2017 Results
29th Aug 20175:25 pmRNSDirector/PDMR Shareholding
23rd Aug 20177:00 amRNSAnnouncement of Split-Up Share Distribution Date
11th Aug 20171:01 pmRNSAppendix to 1H17 and 2Q17 Results
11th Aug 20171:00 pmRNSResults for First Half and Second Quarter of 2017
7th Aug 20177:02 amRNSCall and Presentation to discuss Q2 2017 results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.